Action Potential Venture Capital Ltd. is located in Palo Alto, United States on 364 University Ave. Action Potential Venture Capital Ltd. is rated 3 out of 5 in the category venture capital & private equity in United States. Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices, and invests in companies and technologies that enable the future of targeted and adaptive bioelectronics.
Address
364 University Ave
Company size
1-10 employees
Headquarters
Palo Alto, CA